The development of non-pharmacological interventions (NPIs) is part of France’s 2023-2027 global health research and innovation strategy. This strategy aims to respond to the imperatives of equity and solidarity, to make a greater commitment to disease prevention and health promotion, and to take better account of the interdependencies between climate change, ecosystem protection and health (France Government, 2023).

This development is based on a central organisation in France for research and health issues, INSERM (2024). The NPI Model, the creation of which was supported by an INSERM participatory research seed fund, facilitates the effective and rapid availability of innovations in NPIs for patients and healthcare professionals, from basic research through to dissemination. The ten-year strategy on supportive care published in 2024 has further amplified the need for a standardised evaluation model for NPIs (France Gouvernement, 2024).

In Europe, the European Commission’s DG Health and Food Safety is supporting innovation in the field of NPIs through its 2020-2024 plan (DG Health and Food Safety, 2020). It aims to promote « health, nutrition, mental health and psychosocial supports to communities » from 2022 (European Commission, 2022) and is charting a course towards a European Health Union (McKee and de Ruijter, 2024).

At international level, the WHO has been advocating « self-help interventions » since 2022 (WHO, 2022a), actions to promote mental health since 2022 (WHO, 2022b) and « the most effective and feasible interventions in a national context » since 2021 (WHO, 2021).

As a result, an NPIs ecosystem is being built up, from research to practice, training and delivery. The NPIS learned society is playing its part. It involves all the players, academic and non-academic, to create a genuine value chain for the benefit of science-based personalised and precision medicine, sustainable health and equitable longevity.